Nothing Special   »   [go: up one dir, main page]

Are Incentives Everything? Payment Mechanisms For Health Care Providers in Developing Countries

Download as pdf or txt
Download as pdf or txt
You are on page 1of 21

Public Disclosure Authorized

WPS2624

Are Incentives Everything?


Public Disclosure Authorized

Payment Mechanisms for Health Care


Providers in Developing Countries

Varun Gauri
Public Disclosure Authorized

Development Research Group


The World Bank
vgauri@worldbank.org
Public Disclosure Authorized

The findings, interpretations, and conclusions expressed in this paper are entirely those of
the author and do not necessarily represent the views of the World Bank, its Executive
Directors, or the countries they represent. Policy Research Working Papers describe
research in progress by the author and are published to elicit comments and to further
debate.
Summary: This paper assesses the extent to which provider payment mechanisms can help
developing countries address their leading health care problems. It first identifies four key
problems in the health care systems in developing countries: 1) public facilities, which provide
the bulk of secondary and tertiary health care services in most countries, offer services of poor
quality; 2) providers cannot be enticed to rural and urban marginal areas, leaving large segments
of the population without adequate access to health care; 3) the composition of health services
offered and consumed is sub-optimal; and 4) coordination in the delivery of care, including
referrals, second opinions, and teamwork, is inadequate. The paper examines each problem in
turn and assesses the extent to which changes in provider payments might address it.

Keywords: provider payments, incentives, contracts

1. Introduction

Health care delivery systems involve a variety of actors, including physicians, nurses,
hospitals, pharmacists, and payers, many of whom interact with each other and with
patients in decentralized settings that are difficult to observe. Most, especially physicians,
can influence the kinds, quantities, and quality of health care goods and services
delivered and consumed. Physicians’ routine practices for making appointments,
diagnosing illness conditions, recommending and administering treatments, offering
counseling and health information, charging for services and materials, and referring
patients to their colleagues greatly affect utilization, efficiency, and quality. That is why
so many health care reforms, and still more arguments in favor of other reforms, focus on
the incentives believed to condition those routine practices, and particularly on the
mechanisms for paying providers.

Reforms in the health care systems of developing countries frequently focus on


“getting the incentives right” and aim to use provider payments to optimize the utilization
of scarce health care resources, transform clinical practice, and improve the quality of
care. To what extent can provider payment mechanisms achieve those objectives in
developing country settings? For most readers, it will be not giving away the punch line
to disclose at the beginning that no magic bullet is available, and that, because of data
limitations, selection effects, and numerous confounding variables, a body of convincing
empirical research on the effects of various payment mechanisms on provider behavior in
developing countries is several years away, at the least. But health policy makers and

1
others interested in improving the health systems of developing countries must act in the
interim with imperfect knowledge. For that reason, this paper is written in the spirit of an
essay. It is an effort to glean practical knowledge, from the partial theoretical and
empirical findings that are available, on whether and how to use payment mechanisms in
health care reform in developing countries. The paper first identifies four leading
problems in the health care systems in developing countries. The succeeding sections
reflect on each of the problems in turn, and assess the extent to which changes in provider
payment mechanisms can address it.

2. Health care problems in developing countries

An analysis of provider payments is complicated not only by heterogeneity


among health care providers but by the diversity of institutions, practices, and preferences
in developing countries. This typology, largely based on McPake (1997), divides health
care systems in developing countries into three patterns. The first pattern uses as
exemplars Nepal, Tanzania, many of the smallest and poorest nations in sub-Saharan
Africa. In those countries large public hospitals are located in the capitals and a few of
the largest cities, and smaller public hospitals, clinics, and health posts are scattered in
rural areas. Budget allocations finance public facilities, whose employees are usually
salaried physicians and nurses who sometimes supplement their incomes by selling goods
and services under the table. Patients who have conditions of varying severity crowd
emergency rooms, and little medical information is passed from one facility to another.
Shortages of supplies are common. In rural areas patients also frequent traditional
healers, drug sellers, and semi- trained health providers that work largely in isolation from
the public facilities. Religious orders and philanthropic groups run hospitals and clinics
that people regard more highly than those in the public sector. In the capitals and largest
cities, well-to-do executives, professionals, government officials, and foreign nationals
pay out-of-pocket or draw coverage from the thin insurance market to access better
trained physicians and more technologically sophisticated hospital wards.

Poor countries with larger and more concentrated populations, such as Pakistan
and Kenya, exhibit a second pattern of health care provision. This pattern resembles the
first with one exception: in these countries semi-trained private providers dominate the
supply of health care in most rural and marginal urban areas. These private providers
utilize a mix of Western and indigenous medical concepts, make money purchasing and
reselling drugs from local chemists, often engage in agricultural or other activities part-
time, and have limited contact with the formal, public health care system. Patients are

2
usually uninsured and pay these providers out-of-pocket, resulting in substantial
household outlays. For example, about three-quarters of health expenditures in India
come directly from households. (Chakraborty 1998)

Middle- income countries such as Chile, Mexico, Thailand, and South Africa, have
a distinct, third pattern of health care provision. Risk-pooling, often financed with formal
sector payroll taxes, is far more common. A government- managed social security
organization usually collects taxes and pays physicians and hospitals, which are either
public or contracted private providers. Most of these countries also have general revenue-
financed hospitals and clinics for informal sector workers, and growing or already
substantial private insurance markets for the relatively well-off in the larger cities.

These patterns are heuristic devices only, and many countries’ systems are
hybrids, with different patterns predominating in distinct geographic areas. Nevertheless,
the typology helps to illuminate the main challenges facing the health systems of
developing countries and to make clear what is hoped for from reforms that implement
new incentive structures. Four key institutional problems facing the health systems of
developing countries emerge from the preceding account: 1) public facilities, which
provide the bulk of secondary and tertiary health care services in most countries, offer
services of poor quality; 2) the composition of health services offered and consumed is
sub-optimal; 3) providers cannot be enticed to rural and urban marginal areas, leaving
large segments of the population without adequate access to health care; and 4) the
referral system and coordination in the delivery of care is inadequate. The next sections
analyze the extent to which getting the incentives right might help address each of these
problems.

3. Improving the quality of care in public hospitals

Most public hospitals in developing countries are financed through budget


allocations that are not directly related to the amount and quality of health care services
they provide. These hospitals are nominally under the nominal supervision of a health
ministry, and gross violations of expected norms can lead to dismissal of hospital
directors or staff and penalties in the form of reduced budgets or the withdrawal of
certain privileges in subsequent years. But in practice supervision is weak, and penalties
for poor performance are the exception. The most commonly suggested change in
provider payments for hospitals is to make hospitals residual claimants on revenues,
and/or to expose hospitals to competitive markets through the establishment of renewable
and competitively offered contracts for specific services. The motivation for these ideas

3
comes from classical agency theory, which holds that time-based payments for services
(salaries or budgets) do not charge agents (in this case hospitals) for on-the-job leisure.
(Harding and Preker 2000) As a result, the managers of public and not- for-profit
organizations do not personally lose income when they hold a Friday afternoon office
party, misplace a patient’s file, or otherwise slack off.

What do contracts that do impose pena lties on hospital managers for


inattentiveness and lethargy look like? Optimal contracts turn out to be complex
agreements that attempt to reconcile competing objectives. Most analyses of these
contracts, drawing from classical agency theory, focus on the tradeoff between risk and
efficiency. Given that patients do not pay the marginal cost of health care in hospitals,
either because they have insurance coverage or because governments offer subsidies, and
that the amount and type of health care needed when a patient arrives at a hospital are
unknown, either the hospital or the payer must assume financial risk. Hospitals will
refuse contracts in which they are paid a flat rate to treat all presenting patients, but
contracts that reimburse hospitals for all incurred costs provide no incentives to reduce
unit costs and encourage hospitals to see as many patients as possible. The optimal
solution lies in the middle. Under some conditions, transferring some but not all risk to
providers, some “supply-side cost sharing” or “partial capitation,” can improve social
welfare by mitigating the excess consumption from moral hazard without eviscerating the
risk-pooling function of insurance, which imposing very high co-payments or user fees
would do. (Pope 1989, Ellis and McGuire 1990, Ellis 1998, Newhouse 1998) In practice,
many contracted hospitals are paid, both in industrialized and in some low and middle-
income countries, such as the Kyrgyz Republic and Brazil, on a per patient basis adjusted
for the resources associated with the diagnosis at entry, a method inspired by the
diagnosis-related groups (DRGs) in the U.S. Medicare system. This type of payment
method assumes that hospitals can influence patient decision making about how many
resources to consume after they are admitted, and that that influence should be exploited
by payers to dampen moral hazard. Other countries, such as Germany and the Czech
Republic, reimburse contracted hospitals on the basis of the number and case- mix of
patients, but at a price that declines as the volume of patients increases, a method used in
Germany, the Czech Republic, and elsewhere. This contract assumes more explicitly that
hospitals have market power over patients because of the lack of competitors or because
of asymmetric information with patients, that hospitals use that power to entice larger
numbers of patients to their facilities, and that, therefore, hospitals should be reimbursed
at rates less than marginal cost over some ranges.

4
The literature on the tradeoff between risk and efficiency for hospitals is directly
relevant for several pattern three countries, such as the Mexico and Argentina, where the
rate of increase in medical prices is an emerging priority. But pattern one and two
developing country markets do not have wid espread third-party payment, do not have
private hospitals in large numbers, and most have weak information systems for reporting
treatment quantities and marginal costs. Cost-containment is achieved simply in those
contexts – by shrinking the public sector health budget. But budgetary caps are ham-
fisted instruments that force facilities to ration care arbitrarily, creating confusion,
distrust, patient dumping, and steadily eroding the credibility of government incentives
for providers. Explicit rationing would create less arbitrary distribution rules, and limiting
government financing to packages of basic, cost-effective services has been proposed
(World Bank 1993), but most governments resist official rationing on political and
normative grounds. Another solution to the moral hazard problem that does not rely on
supply-side cost-sharing is to encourage the creation of medical savings accounts, as
Singapore and Hong Kong have done, and to charge patients the full price of health care;
but medical savings accounts need to be combined with insurance for more expensive
and catastrophic care for hospital services that, in pattern one and two countries, are not
feasible in the short- to medium- term. By far the most common means to limit consumer
demand are informal payments, whether proscribed, tolerated, or officially sanctioned as
user fees. These are widespread in all three patterns of health care systems, but especially
in patterns one and two.

Empirical studies on the risk-efficiency tradeoff have found that supply-side cost-
sharing seems to be associated with shorter average length-of-stay in hospitals. There is
as yet no conclusive evidence on whether supply-side cost sharing is forcing cuts in
medically necessary care or are otherwise damaging the quality of care provided; but the
concern that they might fuels research in the area. One study have found evidence that
decreases in reimbursement associated with prospective payment in the United States
were associated with inpatient hospital mortality rates, but not with mortality in the year
after discharge. (Cutler 1995)

The possibility that providers are skimping on care-giving leads to the recognition
that the classical agency model is not the full story. There is more going on than the
transfer of risk to providers. When agents perform multiple tasks, basing rewards on just
one or two of them can distort agents’ incentives, leading to perverse outcomes.
Hospitals, among the most complex organizations in the modern world, obviously
perform multiple tasks, including patient intake, emergency care, thousands of different

5
medical procedures, patient education, billing and payment, training residents and interns,
case conferences and grand rounds, epidemiological surveillance, charity, procuring new
equipment, stocking pharmaceuticals, disposing biohazards, building construction, and
fundraising. Basing hospital contracts on a few indicators, even fundamental ones such as
patient intake, bed days provided, or risk-adjusted diagnosis at entry, might compromise
other objectives, such as the quality of care delivered.

A number of theoretical models attempt to identify optimal payment methods


when both efficiency and quality enter into the payer’s objective function. One of these
papers departs from the common premise in the literature that higher quality health care
is equivalent to higher treatment levels, and it explores the possibility of cost-reducing
quality improvements and technological spillovers. (Kesteloot and Voet 1998) Another
finds that managerial limits, such as HMO utilization protocols, combined with
copayments can reduce the reliance on supply-side cost sharing to dampen moral hazard.
(Pauly 1998) A third finds that when patients cannot monitor the quality of care, first best
contracts are not possible because “the purchaser has only two instruments [quantities
and cost], but three margins [quantities, quality, and cost-reducing effort] to induce the
hospital to get right”; and that second-best outcomes depend on “benevolence,” or the
extent to which providers value patient well-being. (Chalkley and Malcolmson 1998)
Where patients observe and respond to physician effort and quality, the existence of
optimal outcomes depends on constraints for truthful reporting (Ma and McGuire 1997)
and on whether costs are known to the payer and on the dimensionality of quality. (Ma
1994) A general conclusion is that a “a consistent finding from this literature is that
mixed reimbursement systems are necessary to optimally balance cost and quality,”
(Dranove and Satterthwaite 2000) but how much supply-side risk sharing is optimal
depends on parameters such as beneficence, competition, and the elasticity of demand for
quality.

That suggests some of the problems that limit the applicability of these models.
When retrospective reimbursements are set below marginal cost (there is supply-side cost
sharing), physicians have no incentive to exert effort above the minimal level. Corner
solutions result unless physicians value their patients’ well-being (“beneficence”) or
unless patients set their demand levels after observing physician effort. In the former
case, the existence of provider beneficence increases health care utilization at any given
level of supply- or demand- side cost sharing. So some writers have noted that payers can
“exploit ‘ethical’ behavior” to extract greater physician effort, by increasing copayments
(Ma and McGuire 1997) or lowering physician reimbursement rates, which also saves

6
(presumably distortionary) tax revenues. (Ma 1994) But this understanding of
“beneficence” as an exogenous characteristic of providers is simplistic. In reality,
physicians will become less beneficent once they observe payers extracting effort from
them. This is an example of the way in which the use of extrinsic incentives might crowd
out intrinsic incentives (Kreps 1998), and how economic organization can change agents’
objectives. (Bowles 1998). There is evidence that intrinsic incentives motivate the
behavior of social workers (Heckman 1997), and they are undoubtedly critical for
physicians and hospitals as well. (Newhouse 1970) Designing incentives systems that
support, rather than detract from provider beneficence, is a real concern that, though
difficult to document, deserves careful consideration when new payment systems are
being considered.

Evidence of distortionary effects of new payment systems is scant because


measures of the other hospital objectives are not easily available, but examples from
other industries abound. Analyses of a job-training program in the United States in which
training agencies were paid on the basis of the salaries and employment rates of their
clients found evidence that agencies chose to work with the more employable clients in
the eligible population, and that employment and salaries at three months, the indicator
on which payments were made, were in fact not correlated with long-term earnings and
employment. (Cragg 1997, Heckman 1996) In another study, paying mutual fund
mangers on the basis of asset size was related to risky portfolio choices, even among
conservative funds, because the demand for funds exhibited a non- linear relationship with
rates of return, with high elasticities of demand at rates above 20%. (Chevalier and
Ellison 1997, cited in Prendergast 1998) One noteworthy example from health care
involves a system in New York state in which a cardiac surgeons were penalized for high
mortality rates. Evidence suggests that the probability of a patient being rejected for
cardiac surgery under the system increased with case risk and when the surgeon’s
mortality rates approached the “high mortality” rate threshold. (Leventis 1998) Because
health care providers can decline to decline to offer non-emergency care, and because
third parties cannot easily determine the reasons for the refusal, linking hospital payments
to quality measures could lead to perverse outcomes in almost any setting, and
particularly in developing countries, where information systems are generally weak.
Concerns like these regarding gaming and task complexity motivate the use of subjective
performance evaluations, in which employers sum up the overall contribution of an
employee to the firm’s objectives. But the relationship between payers and contracted
provider is by nature more distant than that between employee and a supervisor, and
observing the work of contracted hospitals would be difficult for payers. In addition,

7
summarizing the overall value of a hospital is complex (a problem that is perhaps on par
with the difficulty of ranking the performance of national health systems), so contracts
with hospitals cannot easily utilize quality measures or other global performance
indicators to condition payments.

If consumer demand, or exit signals, can force improvements in the quality of


hospital care, payers will be able to avoid the technical problem of conditioning
reimbursement contracts on quality variables. They could focus on the efficiency and risk
tradeoff and let the marketplace deal with quality issues. Several theoretical models
address this issue, including two tha t hypothesize interactions in which patients set
demand after observing the effort or quality of providers (Ma and McGuire 1997) and
engage in a bargaining game with physicians (Ellis and McGuire 1990). But these models
abstract from a complex clinical reality. The asymmetric power of physicians regarding
diagnosis and treatment undoubtedly varies. It probably is highest in hospitals, declines
with patient education, is smaller in cases involving minor and familiar complaints, and
might not exist at all in preventive care or when the patient is not ill. (Friedson 1989)
There is some evidence consistent with the idea that patients are aware of and do respond
to crude measures of hospital quality, such as the availability of drugs and infrastructure
(Leonard 2000), but there are conflicting findings in other settings. For instance, in New
York state, despite the availability of mortality measures for cardiac surgeons and
hospitals, one study found that in making treatment choices both patients and purchasers
prioritize convenience and cost over clinical quality measures. (Jencks 2000) Still, even if
patients can observe average hospital quality, patients’ choices inside hospitals are
limited, as is, therefore, the information conveyed by patient demand. If, as is generally
the case, hospital physician incomes are linked to the number of procedures performed or
the number of procedures performed is otherwise important for developing expertise or
reputation, and if professional referrals and organizational protocols, not patient choice,
determine demand for a physicians’ services within hospitals, physicians are likely to
have stronger incentives to please their colleagues than their patients. While professional
referrals and case reviews remain best available check on medical quality, they do blunt
the effect of exit signals.

That is another way of way saying that granting autonomy to, corporatizing, or
privatizing a public hospital, even in a competitive market with informed consumers,
does not by itself resolve principal-agent problems within the facility. Lab workers,
nurses, doctors, and others often have divergent interests, and the use of high-powered
incentives could intensify conflicts. As two theorists note, “the use of low-powered

8
incentives within the firm, although sometimes lamented as one of the major
disadvantages of internal organization, is also an important vehicle for inspiring
cooperation and coordination.” (Holmstrom and Milgrom 1994, cited in Gibbons 1998).
In addition, doctors have unusual power in comparison to employees in most firms: they
usually enjoy the power, and often the exclusive legal authority, to admit and discharge
patients in hospitals. They, rather than a CEO or senior management, directly control the
key short-term drivers of costs and revenues of their organization; and exposing the
mangers of a hospital or its board to markets forces will not raise the price of on-the-job
leisure for hospital staff if doctor’s practices do not change (and if the information and
assistance that labs and nurses provide doctors do not support changes in treatment
protocols). Private or corporate hospitals can, in turn, make doctors residual claimants on
revenues as well, or hire them with renewable contracts if public sector hiring rules allow
it; but the effects of profit-sharing and other schemes that tie physicians’ income to
corporate performance will be diluted as a function of the size of the hospital. And
whether or not hospitals create such incentive schemes, and how they do it, will vary.
Because of the uncertainties regarding optimal contracts sketched above, the separation
of financing from provision probably will not result in a unique, let alone a first best, set
of incentives within hospitals. There are few if any studies regarding the incentive
schemes adopted by newly corporatized hospitals, but, if evidence from HMOs operating
in competitive markets is a guide, no single pattern is likely to emerge. In the U.S.,
Hillman and others (1992) found that one-third of HMOs in their sample transferred
payments to an intermediate entity (the medical staff of a hospital or a physician group),
not to physicians themselves, and that half of the intermediate entities that were paid by
the HMO on a capitation basis went on to pay primary care physicians on some other
basis, fee-for-service or salary. Why physicians behave they way they do, and what
instruments should be used to motivate them, remains unclear. Existing models of
physician behavior explain less than 10% of inter-physician hours worked (Reinhardt
1999).

There are as of yet no conclusive studies on the relative performance of public


and private or quasi-private providers in developing countries, though some case studies
are available and others are underway. (Over and Watanabe 1999, Govindaraj and
Chawla 1996). Anecdotal evidence suggests that mission hospitals provide better quality
of care than government hospitals in Africa, among other regions; but whether this is
attributable to the ability to hire and fire staff, the recruitment of altruistic personnel,
organizational clarity, or other causes remains unclear. Case studies have found no
systematic difference in productivity between public and private hospitals in Thailand

9
(Pannarunothai and Mills 1997). A literature on the topic is emerging in the United
States, where longitudinal data sets on patient outcomes are available. (Cutler 2000)
There is evidence that patients admitted to for-profit hospitals incur more total
expenditures in the six months after discharge than patients admitted to government
hospitals, but that survival rates are not significantly different between those ownership
types. (Sloan and others 1999) Between for-profit and non-profit private hospitals, there
is little difference in cost and patient outcome measures. (Sloan 1998) One research
program is focusing on ratios of nurses to patients, arguing that they appear to predict
health outcomes better than the juridical status of providers. (Aiken 2000) A fifth U. S.
study found that for-profit hospitals exhibit higher mortality rates among elderly patients
with heart disease than nonprofit hospitals, and that this difference has grown over the
last decade, but that most of this difference in outcomes is due to the location of for-profit
hospitals. That study’s conclusion sums up the principal findings of the empirical
literature to this point: “[T]he small average difference in mortality between for-profit
and not-for-profit hospitals masks an enormous amount of variation in mortality within
each of these ownership types. Overall, these results suggest that factors other than for-
profit status per se may be the main determinants of quality of care in hospitals.”
(McClellan and Staiger 2000)

The strongest arguments for coporatization emerge not from property rights
theory but from accounts of public sector organization. Public bureaucracies, orderly and
regimented hierarchies in the simple, stylized Weberian conception, are in reality often
divided and politicized. The problem for some public mangers is not that they lack over
their agency discretion, as the stylized account suggests, but that they are responsible to
several principals with differing interests. One theoretical model demonstrates that if a
manger can achieve the goal of one principal only at the expense of the goals of the
others, a situation might result in which the principals find it optimal to reward the
manager on the basis of performance criteria that subvert the goals of the other
principals. (Dixit 1997) This account is plausible for public hospitals, which in
developing countries are answerable to ministries of health, education, finance, as well as
to local governments. The account suggests that mission clarification for public hospitals
could allow principals to set clearer performance benchmarks and user higher power
incentives. The same is true for some discrete tasks in the health sector as a whole, such
as immunization: carving out those tasks from others would allow for the use of higher
power incentives and could enhance performance in specific areas.

10
4. Improving the composition of health care utilization

Patients do not always demand and providers do not always deliver the right kind
of health care. Increasing or decreasing the utilization of specific medical procedures as
technologies evolve is a continual health policy problem, and encouraging greater
utilization of public health and preventive care is a preoccupation of public health
officials in industrial and developing countries alike. Financial incentives play a role in
these efforts.
On the demand side, some payers set relative consumer prices with the objective
of promoting certain kinds of health care. Governments, for instance, frequently subsidize
services with large positive externalities, such as immunization and health information.
Private payers set low co-payments for certain preventive services, such as ante- natal
care, on the basis of a calculation that their utilization lowers expected claims for
hospitalization and other costly procedures. Relative consumer prices are occasionally
used to promote specific treatments or devices (say, condoms instead of sterilization), but
their use is not widespread because cross-price elasticities with other health services and
behaviors (say, abstinence or the female condom) are generally unknown or disputed, and
because a complicated, variable co-payment schedule for all health care services would
lead to controversies regarding actuarial fairness and the equitable treatment of different
medical conditions. Co-payments are rarely negative, but paying people to consume
health care with positive externalities might make sense. One comprehensive literature
review identified 11 “randomized trials with quantitative data concerning the effects of
financial incentives (cash, vouchers, lottery tickets, or gifts) on compliance with
medication, medical advice, or medical appointments,” and found that 10 of the 11
studies showed that some form of financial incentives promoted compliance better than
any alternative. (Giuffrida and Torgerson 1997) It is conceivable that specific financial
incentives could “crowd out” altruistic motivations, such as the willingness to donate
blood (Titmuss 1970). But in Brazil and other countries a program that pays poor families
to send their children to school has met with success; and paying poor families to utilize
health services, particularly those with positive externalities, might under some
conditions be an effective way to change utilization patterns in developing countries.

Supply side approaches are more common than demand side ones. Initiatives to
alter the composition of health care utilization by changing the relative reimbursement
rates to providers for various procedures take as given the notion that health care
providers have significant power to induce patient demand, and also make several other
assumptions regarding health care provision. Lowering the relative supply price of a

11
procedure might not increase its utilization if physicians cannot induce patient demand
(the field is competitive, discretion limited, or patient needs and preferences are strong),
if physicians can make up the lost income from some other source (selling more
pharmaceuticals, gaining referrals from colleagues, increasing referrals to labs or other
facilities from which they receive revenue, substituting into patients covered by a payer
that has not lowered the price of the procedure), if physicians prefer to substitute leisure
for the lost income, or if practicing the procedure sufficiently enhances physicians’
reputations. The long-term effects of changes in relative provider prices, including their
impact on entry and exist into specific specialties, is difficult to study empirically but
warrants historical examination. It might be the case that policy decisions regarding
medical training and licensing have a greater (though belated) impact on patient decisions
and service utilization rates than changes in relative prices. (Arrow 1963)

Changing relative provider prices can occur through reimbursement rates from
third-party payers or in the form of specific “target payments” to public or private
providers. Initiatives in this area have taken a number of forms. In the United States and
Canada, “relative value scales” have increased the fees of “cognitive” services, such as
consultations with primary care physicians, relative to some procedural services, such as
surgery and testing. Target payments for immunization and other services have been
provided in the UK, the Czech Republic, and elsewhere. A blueprint for a health system
reform in Brazil, supported by the World Bank and the Inter-American Development
Bank, explicitly targeted the composition of patient demand by attempting to raise the
supply prices of services deemed cost-effective. (World Bank 1996) In addition, some
initiatives have been proposed to use clinical criteria to bundle certain services, such as
surgery and post-acute care under Medicare (Prospective Payment Assessment
Commission 1997) and deliveries with ante-natal care visits (World Bank 2000).

Despite these efforts, detailed studies of the effectiveness of changing utilization


through provider payments is scanty. In Haiti, payments to NGOs based on immunization
rate coverage and other targets produced sharp increases in utilization rates; but the study
did not include control groups (Eichler 2000). There is more evidence that fee changes
can impact specific clinical decisions where medical discretion is large, such as the
balance between cesarean and normal child births (Gruber and others 1999). No effect
was found in an attempt to increase breast cancer screening rates by paying small
financial bonuses to physicians in managed care organizations in the United States, a
finding that the authors attribute to a lack of awareness of the payments among
physicians and to the difficulty of affecting treatment protocols when physicians have

12
multiple payers. (Hillman and others 1998: AJPH) Studies of the effects of general
changes in relative provider prices have found limited and inconclusive effects (Hurley
and Labelle 1995), and one literature review of target payments found only two studies
using randomized controls (both employing non- linear bonus payments based on
immunization rates). One of these studies found a significant effect of target payment,
and the other did not. (Giuffrida and others 2000) Further experiments in developing
countries are certainly warranted, but results to date suggest that marginal changes in
provider payments have a limited effect on the composition of utilization. It might be
more useful to focus on the composition of health care providers (nurses versus doctors,
generalists versus specialists), which can affect health care consumption over the long
term.

5. Attracting physicians to work in outlying areas

Serving in remote areas in deve loping countries constitutes a personal hardship


for physicians, who must forego income from private practices they could establish in
urban areas as well as educational and other opportunities for their children. As a result,
premiums for enticing physicians to serve in those areas must be high. One analysis
based on both the revealed and stated preferences of medical school graduates in
Indonesia found that that bonuses of as much as 100% of salary would be necessary to
attract graduates from Jakarta to the outer islands, but that bonuses of as little as 30%
were required to attract physicians originally from remote regions to return there to
practice after finishing medical school. That study suggested that establishing medical
training centers in outlying areas, hiring public health graduates as rural health center
managers, and increasing the representation of local students in medical schools could
help staff health clinics in peripheral areas. (Chomitz and others 1998) Several countries,
such as Mexico and Indonesia, have compulsory a service requirements in outlying areas
for new physicians. This system helps staff the outer clinics at low cost, but does so
usually at the expensive of a quid pro quo from the government, such as free tuition in
public medical school, guaranteed placement in the civil service, or specialist training,
that carries larger efficiency costs than direct cash subsidies to physicians.

There might a reason, however, that governments recruit younger physicians to


work in rural regions and tie their pay to career opportunities. Monitoring costs are
exceptionally high in those areas, so incentives in the form of piece-work (fee- for-
service) or payments tied to performance measures are nearly impossible to enforce. The
difficulty of monitoring might also increases the risk of perverse effects following from

13
the distortionary incentives associated with those payment structures. For instance,
Palmer and Mills (2000) found that part-time district surgeons in South Africa paid on a
fee-for-service basis expend minimal time and effort on their public sector patients. On
the other hand, salaried physicians can easily shirk on the job because of the isolation in
which they work – indeed, the job, if adequately remunerated, might actually attract
individuals looking for low stress positions. The promise of entry into specialist training
or the civil service essentially constitutes a deferred compensation contract with a large
bonus. Younger physicians might be motivated enough by such contracts to avoid
negative reports from their patients or the itinerant supervisors that do visit them. To
work as an incentive, however, entry into the civil service or specialist training should not
be guaranteed but should be contingent on good performance. But young physicians, who
even with explicit guarantees of a deferred bonus are not attracted in larger numbers to
service in outlying areas, probably will not accept the increase in risk associated with
contingent bonuses (what if the government reneges?) unless paid to do so. A salary
increase and a mixed contract, with both high and low-powered incentives, would result.
A problem with relying on younger physicians to staff rural clinics is that the new
workers have little experience and few opportunities for learning. Recruiting older
clinicians will to serve in those areas is difficult both because the deferred bonus payment
would have to be quite high, and because career concerns will be less effective in solving
the monitoring problem.

6. Referrals and coordination

Problems with referrals and the coordination of health care, while vexing for
health policy makers everywhere, are acute in most developing countries. In most
countries there are too few professional referrals. Patients go directly to emergenc y
rooms and hospital outpatient centers, receive a diagnosis and/or treatment, and return to
their communities with little or no transfer of medical information between the hospital
and their local clinic or health center. In pattern two countries such as India, the private
practitioner working in isolation has an incentive to avoid referring patients and
recommending second opinions –the referring physician might lose a customer if the
patient prefers the colleague. That is a social loss because a physicia n who refers a patient
to a colleague has his work effectively evaluated by the colleague, and the counter-
referral then results in the second colleague being evaluated as well. (Friedson 1989) In
other words, medically indicated professional referrals carry social benefits that the
referring physician cannot internalize: there are positive externalities to professional
referrals. By contrast, lay referrals have a weaker quality control function. Practitioners

14
who rely exclusively on lay referrals, including isolated private providers in developing
countries, are forced to meet patient expectations, dispensing excess pharmaceuticals.
Although professional organizations can encourage referrals, they sometimes prioritize
union interests over quality monitoring, and professional norms that encourage keeping
quiet and not criticizing colleagues can undermine the quality-enhancing potential of
professional referrals.

There exist few studies evaluating explicit incentives for cooperation. Profit-
sharing might promote cooperation, but the incentives tend to be diluted in large
organizations. (Prendergast 1998) One study argues that, theoretically, the use of
promotions or tournaments to reward individuals will be negatively related to helping
behavior, and finds empirical evidence to support the claim. (Drago and Garvey 1998) In
health care, some patterns of payment can affect the frequency of medical referrals.
Weakly monitored physicians on salary exert effort have an incentive to pass off a patient
to a colleague. Withheld payments to physicians, in which payers exclude physicians
from bonuses or withheld payments when their referral rates for laboratory tests or
hospitalizations exceed plan norms, reduce referral rates. Some of the strongest empirical
findings in the provider payment literature document that capitation payments and
fundholding arrangements can reduce hospitalization. In the U.K., the NHS reform that
established general practitioner fundholding has apparently increased the referral power
of general practitioners, though at the expense of a 9-12% increase in transaction costs.
(Le Grand 1999, Klein 1998) One reason many developing countries might chose to pay
for and provide primary health care, even though there are larger market failures in
insurance for catastrophic care, is to use low-powered incentives to establish functioning
referral systems and coordination. There is some evidence, for instance, that private
facilities are less likely to cooperate with public health objectives. In the United States
public hospitals are twice as likely to collaborate, either formally or informally, with
public health departments than not- for-profit hospitals, which in turn are twice as likely
to do so as for-profit hospitals. (Halverson and others 2000) Similarly, there is greater
involvement in preventive activities on the part of public hospitals in Malaysia (Alijunid
and Zwi 1997), though not in Kenya (Berman and others 1995). But low-powered
incentives result in efficiency losses, so some combination of low- and high-powered
incentives, such as those embedded in fundholding, might be able to optimize the balance
between coordination and efficiency. This is speculative at this stage, however, and
further research is needed to determine if and how fundholding arrangements might be
useful in developing countries.

15
7. Conclusion

Most analytical and empirical research on provider payment mechanism has


focused on the distinction between prospective and retrospective payment systems. The
findings of that body of work suggest that prospective payment systems can reduce the
cost of care. But that research to date is inconclusive about or tangential to the largest
problems facing the health systems of developing countries – financing and managing
insurance schemes, improving the quality of care, influencing the composition of
demand, and coordinating medical referrals. To identify the best policy instruments to
address those problems, further research is needed on the relative performance of public
and non-public providers, institutional factors that explain variation in outcomes among
hospitals, factors that affect the demand for health care, the long-term effects of relative
provider prices, informal payments to providers, and mechanisms to coordinate referrals.

On the basis of the research conducted to date, this essay recommends that
experiments and pilot projects for improving public sector hospitals should focus on
mission clarity and organizational simplification, programs for improving the
composition of utilization should experiment with payments to consumers and with
medical and nursing training, initiatives for attracting providers to rural areas should use
explicit deferred compensation contracts to improve monitoring, and that developing
mechanisms for increasing medically indicated professional referrals requires more
research.

References
Aiken, Linda, and others. “Hospital Restructuring: Does It Adversely Affect Care and
Outcomes?” Journal of Nursing Administration, October 2000.

Alderman, Harold, and Lavy, Victor. “Household Responses to Public Health Services: Cost and
Quality Tradeoffs,” The World Bank Research Observer 11, February 1996.

Aljunid, Syed, and Zwi, Anthony. “Public and Private Practitioners in a Rural District of
Malaysia: Complements or Substitutes?” in Bennett, Sara; McPake, Barbara; and Mills,
Anne, editors, Private Health Providers in Developing Countries: Serving the Public
Interest, London: Zed Books, 1997.

Arrow, Kenneth J. “Uncertainty and the Welfare Economics of Medical Care,” The American
Economic Review, December 1963.

16
Berman, Peter, and others. Kenya: Non-Governmental Health Care Provision. Data for Decision
Making Project, Department of Population and International Health, Harvard School of
Public Health, 1995.

Bowles, Samuel. “Endogenous Preferences: The Cultural Consequences of Markets and other
Economic Institutions,” Journal of Economic Literature 36, 1998.

Chakraborty, Sarbani. The Magnitude and Determinants of Technical Quality of Care for Acute
Respiratory Infections (ARI) Among Private Health Providers in Rural West Bengal,
India . Ph D Dissertation, Johns Hopkins University, 1998.

Chalkley, Martin, and Malcomson, James M. “Contracting for Health Services with Unmonitored
Quality,” Economic Journal 108, 1998 b.

Chalkley, Martin, and Malcomson, James M. “Contracting for Health Services When Patient
Demand Does Not Reflect Quality,” Journal of Health Economics 17, 1998.

Chevalier, Judith and Ellison, Glenn. “Risk Taking by Mutual Funds as a Response to
Incentives,” Journal of Political Economy 105 1997.

Chomitz, Kenneth, and others. “What Do Doctors Want? Developing Incentives for Doctors to
Serve in Indonesia’s Rural and Remote Areas,” Policy Research Working Paper 1888,
World Bank, March 1998.

Cragg, Michael. “Performance incentives in the public sector: Evidence from the Job Traiing
Partnership Act,” Journal of Law, Economics, and Organization 13 1997.

Cutler, David, editor. The Changing Hospital Industry: Comparing Not-for-Profit and For-Profit
Institutions, Chicago: University of Chicago Press, 2000.

_____. “The incidence of adverse medical outcomes under prospective payment,” Econometrica
63 1995.

Dixit, Avinash. “Power of Incentives in Private versus Public Organizations,” AEA Papers and
Proceedings May 1997.

Drago, Robert, and Garvey, Gerald. “Incentives for Helping on the Job: Theory and Evidence,”
Journal of Labor Economics 16 (1) 1998.

Dranove, David, and Satterthwaite, Mark. “The Industrial Organization of Health Care Markets,”
in A. J. Culher and J. P. Newhouse, editors, Handbook of Health Economics, Amsterdam:
North-Holland, 2000.

Ellis, Randall. “Creaming, skimping, and dumping: provider competition on the intensive and
extensive margins,” Journal of Health Economics 17 (5), 1998.

Ellis, Randall, and McGuire, Thomas. “Optimal Payment Systems for Health Services” Journal
of Health Economics 9 1990.

17
Friedson, Eliot. Medical Work in America: Essays on Health Care, New Haven: Yale University
Press, 1989.

Glewwe, Paul. “Why Does Mother’s Schooling Raise Health in Developing Countries? Evidence
from Morocco,” The Journal of Human Resources 34, 1999.

Govindaraj, R., and Chawla, M. Recent Experiences with Hospital Autonomy in Developing
Countries – What Can We Learn? Data for Decision Making Project, Department of
Population and International Health, Harvard School of Public Health, 1996.
Gruber, Jon, and others. “Physician Fees and Procedure Intensity: the Case of Cesarean
Delivery,” Journal of Health Economics 18, 1999.

Halverson, Paul, and others. “Working Together? Organizational and Market Determinants of
Collaboration Between Public Health and Medical Care Providers,” American Journal of
Public Health December 2000.

Harding, April, and Preker, Alexander, editors. Innovations in Health Care Delivery:
Organizational Reforms within the Public Sector. World Bank: 2000.

Heckman, James, and others. “Assessing the performance of performance standards in public
bureaucracies,” The American Economic Review May 1997.

Hillman, Alan, and others. “Contractual Arrangements Between HMOs and Primary Care
Physicians: Three-Tiered HMOs and Risk Pools,” Medical Care 30 1992.

Hurley, Jeremiah, and Labelle, Robert. “Relative Fees and the Utilization of Physicians’ Services
in Canada,” Health Economics 4, 1995.
Kesteloot, K., and Voet, N. “Incentives for Cooperation in Quality Improvement among Hospitals
– the Impact of the Reimbursement System,” Journal of Health Economics 17, 1998.

Klein, Rudolf. “Why Britain Is Reorganizing its National Health Service – Yet Again,” Health
Affairs July/August 1998.

Kohn, Linda T., and others, editors. To Err Is Human: Building a Safer Health System,
Washington: Institute of Medicine, 2000.

Kramer, A. M., and others. “Outcome and Utilization Differences for Older Persons with Stroke
in HMO and Fee-for-Service Systems,” Journal of the American Geriatric Society 48,
July 2000.

Lee-Feldstein, A., and others. “The Relationship of HMOs, Health Insurance, and Delivery
Systems to Breast Cancer Outcomes,” Medical Care 38, July 2000.

Le Grand, Julian. “Quasi-Markets and Social Policy.” The Economic Journal 101, September
1991.

18
Le Grand, Julian. “Competition, Cooperation, or Control? Tales from the British NHS,” Health
Affairs, May/June 1999.

Leonard, Kenneth, “Incentives and Rural Health Care Delivery,” in David K. Leonard, editor,
Africa’s Changing Markets for Human and Animal Health Services, London: Macmillan
2000.

Leventis, Andrew. Job Performance and Behavior: Three Empirical Examinations of


Productivity and Incentive Response, Ph D Dissertation, Princeton University, 1998.
Ma, Ching-To Albert, “Health Care Payment Systems: Cost and Quality Incentives,” Journal of
Economics and Management Strategy 3, 1994.

Ma, Ching-To Albert, and McGuire, Thomas G. “Optimal Health Insurance and Provider
Payment,” The American Economic Review 87, September 1997.

McClellan, Frank, and Staiger, Douglas. “Comparing Hospital Quality at For-Profit and Not-for-
Profit Hospitals,” in Cutler, David, editor, The Changing Hospital Industry: Comparing
Not-for-Profit and For-Profit Institutions, Chicago: University of Chicago Press, 2000.

McPake, Barbara. “The Role of the Private Sector in Health Service Provision,” in Bennett, Sara;
McPake, Barbara; and Mills, Anne, editors, Private Health Providers in Developing
Countries: Serving the Public Interest, London: Zed Books, 1997.

Newhouse, Joseph P. “Risk Adjustment: Where Are We Now?” Inquiry 35 1998.

_____. “Toward a Theory of Non-Profit Institution: An Economic Model of Hospital,” American


Economic Review 60, 1970.
Newhouse, J. P., and others. Free for All? Lessons from the RAND Health Insurance Experiment,
Cambridge: Harvard University Press, 1993.

Over, Mead, and Watanabe, Naoko. “Evaluating the Impact of Organizational Reforms in
Hospitals.” The World Bank, 1999.

Pannarunothai, Supasit, and Mills, Anne. “Characteristics of Public and Private Health Care
Providers in a Thai Urban Setting,” in Bennett, Sara; McPake, Barbara; and Mills, Anne,
editors, Private Health Providers in Developing Countries: Serving the Public Interest,
London: Zed Books, 1997.

Pauly, Mark. “Would you like suspenders to go with that belt? An analysis of optimal
combinations of cost sharing and managed care” Journal of Health Economics 18 1999.

Pope, Gregory. “Hospital nonprice competition and Medicare reimbursemetn policy,” Journal of
Health Economics 8 (2) 1989.

Prendergast, Canice, “The Provision of Incentives in Firms,” Journal of Economic Literature 37


March 1999.

19
Prospective Payment Assessment Commission. Report and Recommendations to the Congress
March 1, 1997.

Reinhardt, Uwe. “The Economist’s Model of Physician Behavior,” Journal of the American
Medical Association 281 (5) 1999.

Rice, Thomas. The Economics of Health Reconsidered, Chicago: Health Administration Press,
1998.

Sloan, Frank, and others. “Does Where You are Admitted Make a Difference? An Analysis of
Medicare Data,” NBER Working Paper 6896, January 1999.

Sloan, Frank, and others. “Hospital Ownership and Cost and Quality of Care: Is there a Dime’s
Worth of Difference?” NBER Working Paper 6706, August 1998.

Sprinkle , R. H. “A Moral Economy of American Medicine in the Managed-Care Era,”


Theoretical Medicine and Bioethics, forthcoming.

Titmuss, R. M. The gift relationship: from human blood to social policy. London: Allen and
Unwin, 1970.

Vickrey, B. G., and others. “Management of Multiple Sclerosis Across Managed Care and Fee-
for-Service Systems,” Nephrology 14, November 2000.

Weisbrod, Burton A. “The Health Care Quadrilemma: An Essay on Technological Change,


Insurance, Quality of Care, and Cost Containment,” Journal of Economic Literature 29,
June 1991.

World Bank, “Maternal and Child Health in Brazil,” manuscript, June 2000.
_____. Staff Appraisal Report, Health Sector Reform Project – Reforsus, Report No. 15522-BR,
May 21, 1996.

_____. World Development Report: Investing in Health . World Bank 1993.

20

You might also like